echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Alzheimer's disease antibody therapy application is submitted soon, Eli Lilly updates company structure

    Alzheimer's disease antibody therapy application is submitted soon, Eli Lilly updates company structure

    • Last Update: 2021-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today, Eli Lilly (Eli Lilly and Company) announced that it will modify the company's structure to create the Department of Neuroscience and the Department of Immunology


    From September 5 this year, Lilly Bio-Medicines will be divided into two business units: Lilly Neuroscience and Lilly Immunology


    Currently, Dr.


    Mr.


    Reference materials:

    [1] Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units.


    (The original text has been deleted)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.